Table 1. Comparison of baseline data between CTC-test group and no CTC-test group.
| Variables | Total (n=328) (%) | CTC-test (n=50) (%) | No CTC-test (n=278) (%) | ꭓ2 | P value |
|---|---|---|---|---|---|
| Age, years | 0.12 | 0.728 | |||
| <50 | 137 (41.8) | 22 (6.7) | 115 (35.1) | ||
| ≥50 | 191 (58.2) | 28 (8.5) | 163 (49.7) | ||
| Gender | 2.220 | 0.36 | |||
| Male | 296 (80.2) | 48 (14.6) | 248 (75.6) | ||
| Female | 32 (9.8) | 2 (0.6) | 30 (9.1) | ||
| AFP (ìg/L) | 0.150 | 0.699 | |||
| ≤400 | 237 (72.3) | 35 (10.7) | 202 (61.6) | ||
| >400 | 91 (27.7) | 15 (4.6) | 76 (23.2) | ||
| Cirrhosis | 0.005 | 0.946 | |||
| No | 19 (5.8) | 3 (0.9) | 16 (4.9) | ||
| Yes | 309 (94.2) | 47 (14.3) | 262 (79.9) | ||
| TNM staging | 2.275 | 0.517 | |||
| I | 29 (8.8) | 4 (1.2) | 25 (7.6) | ||
| II | 103 (31.4) | 16 (4.9) | 87 (26.5) | ||
| III | 174 (53.0) | 29 (8.8) | 145 (44.2) | ||
| IV | 22 (6.7) | 1 (0.3) | 21 (6.4) |
CTC, circulating tumor cells; AFP, preoperative alpha-fetoprotein.